An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies

Memorial Sloan Kettering Cancer Center, New York

Weill Medical College of Cornell University, New York

Dent Neurologic Institute, Amherst

Winship Cancer Institute, Emory University, Atlanta

Mayo Clinic, Jacksonville

Cancer Institute of Orlando, Orlando

Moffitt Cancer Center, Tampa

University Hematology Oncology Care, LLC, Cincinnati

The Ohio State University, Columbus

Good Samaritan Hospital, Cincinnati

Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit

University of Wisconsin, Madison

Evanston Northwestern Healthcare, Evanston

Feinberg School of Medicine, Northwestern University, Chicago

University of Colorado Cancer Center, Aurora

Colorado Neurological Institute Center for Brain & Spinal Tumors, Englewood

Barrow Neurological Institute, Phoenix

UC San Diego Cancer Center, San Diego

Hoag Memorial Hospital Presbyterian, Newport Beach

Stanford University Medical Center, Palo Alto

UC Davis Medical Center, Division of Medical Oncology, Sacramento

Oregon Clinic, Portland

Virginia Mason Clinic, Seattle

Beth Israel Deaconess Medical Center, Boston

Medical College of Wisconsin, Milwaukee

Cross Cancer Institute, Edmonton

CancerCare Manitoba, Winnipeg

The Moncton Hospital, Moncton

Queen Elizabeth II Health Sciences Center, Halifax

Caner Centre of Southwestern Ontario/ Kingston General Hospital, Kingston

Ottawa Regional Cancer Center, Ottawa

Sunnybrook and Women's College Health Sciences Center, Toronto